Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
Titel:
Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
Auteur:
Ribeiro, Beatriz Felicio Miranda, Eliana C M de Albuquerque, Dulcinéia Martins Delamain, Márcia T Oliveira-Duarte, Gislaine Almeida, Maria Helena Vergílio, Bruna da Silveira, Rosana Antunes Oliveira-Duarte, Vagner Lorand-Metze, Irene De Souza, Carmino A Pagnano, Katia B B